Analysis of HLA-A24-restricted peptides of carcinoembryonic antigen using a novel structure-based peptide-HLA docking algorithm

Cancer Science

Volumn 102, Issue 4, 2011, Pages 690-696

  Nakamura, Yoji ^a,b   Tai, Sachiko ^a   Oshita, Chie ^a   Iizuka, Akira ^a   Ashizawa, Tadashi ^a   Saito, Shuji ^a   Yamaguchi, Shigeki ^a   Kondo, Haruhiko ^a   Yamaguchi, Ken ^a   Akiyama, Yasuto ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

^b FISHERIES RESEARCH AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN HLA A24 1 PEPTIDE; CARCINOEMBRYONIC ANTIGEN HLA A24 10 PEPTIDE; CARCINOEMBRYONIC ANTIGEN HLA A24 2 PEPTIDE; CARCINOEMBRYONIC ANTIGEN HLA A24 3 PEPTIDE; CARCINOEMBRYONIC ANTIGEN HLA A24 4 PEPTIDE; CARCINOEMBRYONIC ANTIGEN HLA A24 5 PEPTIDE; CARCINOEMBRYONIC ANTIGEN HLA A24 6 PEPTIDE; CARCINOEMBRYONIC ANTIGEN HLA A24 7 PEPTIDE; CARCINOEMBRYONIC ANTIGEN HLA A24 8 PEPTIDE; CARCINOEMBRYONIC ANTIGEN HLA A24 9 PEPTIDE; GAMMA INTERFERON; HLA A24 ANTIGEN; PEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BIOINFORMATICS; COMPUTER MODEL; CONTROLLED STUDY; CRYSTAL STRUCTURE; HUMAN; IMMUNOGENICITY; INTERFERON PRODUCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR DOCKING; PRIORITY JOURNAL;

ANTIGENS, NEOPLASM; CARCINOEMBRYONIC ANTIGEN; COMPUTER SIMULATION; DATABASES, FACTUAL; HLA-A ANTIGENS; HUMANS; INTERFERON-GAMMA; NEOPLASMS; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 79952772145     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01866.x     Document Type: Article

References (30)

1. Onizawa S, Watanabe S, Yagura T, Yasutomi M, Yamamura Y. Radioimmunoassay of carcinoembryonic antigen and clinical significance of its level in plasma. Gann 1976; 67: 371-8.
2. Tsai HL, Chu KS, Huang YH et al. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection. J Surg Oncol 2009; 100: 736-43.
3. Jokerst JV, Raamanathan A, Christodoulides N et al. Nano-bio-chips for high performance multiplexed protein detection: determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels. Biosens Bioelectron 2009; 24: 3622-9.
4. Kawashima I, Hudson SJ, Tsai V et al. The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors. Hum Immunol 1998; 59: 1-14.
5. Kavanagh B, Ko A, Venook A et al. Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides. J Immunother 2007; 30: 762-72.
6. Pickford WJ, Watson AJ, Barker RN. Different forms of helper tolerance to carcinoembryonic antigen: ignorance and regulation. Clin Cancer Res 2007; 13: 4528-37.
7. + T cells of lung cancer patients. J Immunol 2006; 176: 5093-9.
8. Iero M, Squarcina P, Romero P et al. Low TCR avidity and lack of tumor cell recognition in CD8(+) T cells primed with the CEA-analogue CAP1-6D peptide. Cancer Immunol Immunother 2007; 56: 1979-91.
9. Nukaya I, Yasumoto M, Iwasaki T et al. Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T lymphocyte. Int J Cancer 1999; 80: 92-7.
10. Matsuda K, Tsunoda T, Tanaka H et al. Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide-pulsed dendritic cells. Cancer Immunol Immunother 2004; 53: 609-16.
11. Itoh T, Ueda Y, Kawashima I et al. Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen. Cancer Immunol Immunother 2002; 51: 99-106.
12. Ueda Y, Itoh T, Nukaya I et al. Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas. Int J Oncol 2004; 24: 909-17.
13. Ojima T, Iwahashi M, Nakamura M et al. Streptococcal preparation OK-432 promotes the capacity of dendritic cells (DCs) to prime carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocyte responses induced with genetically modified DCs that express CEA. Int J Oncol 2008; 32: 459-66.
14. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993; 234: 779-815.
15. Morris GM, Goodsell DS, Halliday RS et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 1998; 19: 1639-62.
16. Berman HM, Battistuz T, Bhat TN et al. The Protein Data Bank. Acta Crystallogr D Biol Crystallogr 2002; 58: 899-907.
17. Knorr R, Trzeciak A, Bannwarth W, Gillessen D. New coupling reagents in peptide chemistry. Tetrahedron Lett 1989; 30: 1927-30.
18. Kuzushima K, Hayashi N, Kimura H, Tsurumi T. Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay. Blood 2001; 98: 1872-81.
19. Abbas AK, Lichtman AH, Pillai S. The major histocompatibility complex. In: Abbas AK, Lichtman AH, Pillai S, eds. Cellular and Molecular Immunology, 6th edn. Philadelphia: Saunders, 2010; 97-111.
20. Sieker F, May A, Zacharias M. Predicting affinity and specificity of antigenic peptide binding to major histocompatibility class I molecules. Curr Protein Pept Sci 2009; 10: 286-96.
21. Schiewe AJ, Hawworth IS. Structure-based prediction of MHC-peptide association: algorithm comparison and application to cancer vaccine design. J Mol Graph Model 2007; 26: 667-75.
22. Shastri N. Needles in haystacks: identifying specific peptide antigens for T cells. Curr Opin Immunol 1996; 8: 271-7.
23. Pelte C, Cherepnev G, Wang Y, Schoenemann C, Volk HD, Kern F. Random screening of proteins for HLA-A*0201-binding nine-amino acid peptides is not sufficient for identifying CD8 T cell epitopes recognized in the context of HLA-A*0201. J Immunol 2004; 172: 6783-9.
24. Logean A, Rognan D. Recovery of known T-cell epitopes by computational scanning of a viral genome. J Comput Aided Mol Des 2002; 16: 229-43.
25. Desmet J, Meersseman G, Boutonnet N et al. Anchor profiles of HLA-specific peptides: analysis by a novel affinity scoring method and experimental validation. Proteins 2005; 58: 53-69.
26. Fuhrmann J, Rurainski A, Lenhof HP, Neumann D. A new Lamarckian genetic algorithm for flexible ligand-receptor docking. J Comput Chem 2010; 31: 1911-8.
27. Kazansky DB. Intrathymic selection: new insight into tumor immunology. Adv Exp Med Biol 2007; 601: 133-44.
28. Bui HH, Schiewe AJ, von Grafenstein H, Haworth LS. Structural prediction of peptides binding to MHC class I molecules. Proteins 2006; 63: 43-52.
29. Rammensee HG, Bachmann J, Emmerich NN, Bachor OA, Stevanovic S. SYFPEITHI: database for MHC ligands and peptides motifs. Immunogenetics 1999; 50: 213-9.
30. Buus S, Lauemoller SL, Worning P et al. Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens 2003; 62: 378-84.